DKFMA-102 is under clinical development by Dongkook Pharmaceutical and currently in Phase III for Prostate Cancer.
Beijing National Laboratory for Molecular Sciences, Key Laboratory of Colloid and Interface and Thermodynamics, Center for Carbon Neutral Chemistry Institute of Chemistry, Chinese Academy of Sciences, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback